Generate Biomedicines

Biotech & Life Sciences · Somerville, United States · Founded 2020 · IPO 2026

Pioneering Generative Biology to create breakthrough medicines

Valuation $2.04B

Revenue $26M

Power Law Unicorn$1–10B valuation tier Colt$25–100M revenue

Knowledge graph

News MiRABO Biotechnology raises $2.9M pre-Series A for its antibody drug AI Aug 20, 2026

Market map Peptides: The Next Drug Modality Stack Apr 10, 2026

Talent graph

Generate Biomedicines's talent

Book a demo to see the people

Employees mapped 334 incl. 26 AI specialists

Founders /100 quality score

Key operators 29 quality /100

Potential founders likely future founders

Startup mafia 4 alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

14 investors on Generate Biomedicines's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 14 investors entered at this stage

Samsung Life Science Fund

March Capital Partners

Abu Dhabi Investment Authority

Alaska Permanent Fund

T. Rowe Price

ARCH Venture Partners

Pictet

Morningside

Fidelity Investments

Amgen

NVentures

Flagship Pioneering

MAPS Capital Management

Altitude Life Science Ventures

Generate Biomedicines mafia

Startups founded by Generate Biomedicines alumni

Former Generate Biomedicines employees who went on to start their own companies. Sorted by Dealroom signal score.

Lila SciencesEst. 2022

Geoffrey von MaltzahnUnited States

Signal score97

AbiologicsEst. 2020

Avak KahvejianUnited States

Signal score90

Gate BioscienceEst. 2021

JMJordi Mata-FinkUnited States

Signal score76

Montai HealthEst. 2022

Noubar AfeyanUnited States

Signal score68

Book a demo to explore the full alumni network →

Global footprint

Where Generate Biomedicines has talent and traffic

Workforce by country

5 countries with
team presence

🇺🇸 United States98.8%

🇦🇪 United Arab Emirates0.4%

🇬🇧 United Kingdom0.4%

🇨🇦 Canada0.4%

🇨🇳 China0.4%

5 countries shown

Web traffic by country

19K monthly visits
across markets

🇺🇸 United States77.9%

🏳️ Korea4.7%

🏳️ Republic of4.2%

🇮🇳 India4.2%

🇬🇧 United Kingdom3.2%

Top 5 markets shown

Patent intelligence

$396k patent portfolio · 8 active families

Estimated portfolio value

$396k

0.02% of market cap · 7.4× smaller than top peer Owkin ($3M)

8 active patent families

Where Generate Biomedicines innovates AlgorithmAntigen Binding FragmentAntigen bindingBioinformaticsGlycoprotein

Where Generate Biomedicines concentrates vs peers

Each axis is a top-10 topic across Generate Biomedicines and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Generate Biomedicines

An AI-synthesized read of the highest-engagement posts about Generate Biomedicines on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Generate Biomedicines on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles